How should I manage an adult post‑coronary‑artery bypass grafting patient with severe ischemic heart disease (left ventricular ejection fraction ≈ 35 %) who developed acute pancreatitis, septic shock and bilateral adrenal hemorrhage with evolving infarction, and who remains hypotensive when norepinephrine is weaned despite a normal 8‑am cortisol level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bilateral Adrenal Hemorrhage with Persistent Vasopressor Dependence Post-CABG

Despite a normal 8 AM cortisol level, this patient requires immediate empiric stress-dose hydrocortisone because a single random cortisol measurement cannot exclude critical illness-related corticosteroid insufficiency in the setting of bilateral adrenal hemorrhage, septic shock, and inability to wean vasopressors. 1, 2, 3

Why the Normal 8 AM Cortisol Is Misleading

  • A random cortisol level—even if "normal" in absolute terms—does not reflect adrenal reserve or the capacity to mount an adequate stress response during septic shock and bilateral adrenal infarction. 2, 3
  • In septic shock, a baseline cortisol <25 µg/dL (or <250 nmol/L) is considered insufficient, but even values above this threshold may be inadequate if the patient cannot wean from vasopressors despite clinical improvement in other parameters. 2
  • Bilateral adrenal hemorrhage with evolving infarction directly impairs cortisol synthesis capacity, regardless of what a single morning cortisol shows. 4
  • The inability to taper norepinephrine despite resolution of pancreatitis and absence of other complaints is a clinical hallmark of adrenal insufficiency in critical illness. 1, 2

Immediate Therapeutic Intervention

Initiate stress-dose hydrocortisone 100 mg intravenously every 8 hours (total 300 mg/day) immediately, without waiting for further cortisol testing. 5, 1

  • This regimen provides both glucocorticoid and mineralocorticoid activity necessary for vasopressor weaning in septic shock with adrenal insufficiency. 1
  • Continue hydrocortisone for at least 7 days or until vasopressors are successfully weaned and hemodynamic stability is achieved. 1
  • Add fludrocortisone 50 µg orally once daily if the patient can tolerate enteral medications, as this provides additional mineralocorticoid support. 1

Vasopressor Management Strategy

Maintain norepinephrine at the current dose (targeting MAP ≥65 mmHg and systolic BP >90 mmHg) while initiating hydrocortisone; attempt to wean norepinephrine 24–48 hours after starting corticosteroid replacement. 6, 7, 8

  • In cardiogenic shock with reduced LVEF (35%), norepinephrine should have been added only after optimizing volume status and initiating inotropic support with dobutamine. 6, 8
  • However, given the current clinical scenario with bilateral adrenal hemorrhage and septic shock, continuing norepinephrine while treating adrenal insufficiency is appropriate. 6, 7
  • Monitor for improvement in vasopressor requirements within 24 hours of starting hydrocortisone—95% of steroid-responsive patients show hemodynamic improvement within this timeframe. 2

Diagnostic Confirmation (Perform After Treatment Initiation)

  • Measure baseline cortisol and ACTH levels before the next dose of hydrocortisone, but do not delay treatment to obtain these results. 1, 2
  • A cosyntropin stimulation test (250 µg IV) can be performed, but in the setting of bilateral adrenal hemorrhage on CT, the diagnosis of adrenal insufficiency is essentially confirmed by imaging alone. 4
  • A cortisol increment <9 µg/dL after cosyntropin administration confirms adrenal insufficiency, but treatment should not be withheld pending this test. 1

Monitoring Parameters During Hydrocortisone Therapy

  • Hemodynamic response: Ability to reduce norepinephrine dose by ≥50% within 24–48 hours indicates steroid responsiveness. 2
  • Electrolytes: Monitor serum sodium and potassium daily, as hydrocortisone has mineralocorticoid effects that may cause sodium retention and potassium wasting. 5
  • Blood pressure: Target MAP ≥65 mmHg and systolic BP >90 mmHg; avoid excessive hypertension (systolic >140 mmHg) which may strain the compromised left ventricle (LVEF 35%). 6, 7
  • Cardiac output markers: Urine output >0.5 mL/kg/hr, lactate clearance, and mental status improvement. 6, 7

Long-Term Corticosteroid Management

  • After successful vasopressor weaning and clinical stabilization, do not abruptly discontinue hydrocortisone—taper gradually over 5–7 days to prevent rebound hypotension. 5, 1
  • Transition to oral hydrocortisone 15–20 mg in the morning and 5–10 mg in the afternoon (total 20–30 mg/day) once the patient is stable and tolerating oral intake. 5
  • Obtain repeat CT abdomen at 4–6 weeks to assess adrenal recovery; most patients with bilateral adrenal hemorrhage require lifelong glucocorticoid and mineralocorticoid replacement. 4
  • Arrange endocrinology follow-up for long-term management, stress-dosing education, and consideration of adrenal recovery testing (cosyntropin stimulation test) at 3–6 months. 4, 3

Critical Pitfalls to Avoid

  • Do not rely on a single random cortisol level to exclude adrenal insufficiency in critical illness—the diagnosis is clinical, supported by imaging showing bilateral adrenal hemorrhage. 2, 4, 3
  • Do not use dopamine as an alternative vasopressor; it provides no renal protection, increases arrhythmia risk (particularly dangerous in a patient with IHD and LVEF 35%), and is inferior to norepinephrine. 6, 7
  • Do not delay hydrocortisone therapy to perform diagnostic testing—bilateral adrenal hemorrhage on CT in a vasopressor-dependent patient is sufficient indication for empiric treatment. 1, 4
  • Do not abruptly stop hydrocortisone after vasopressor weaning; taper gradually to avoid adrenal crisis. 5, 1

Special Considerations for This Patient

  • The combination of recent CABG, septic shock from pancreatitis, and anticoagulation (likely for IHD) are all risk factors for bilateral adrenal hemorrhage. 4
  • The patient's reduced LVEF (35%) makes him particularly vulnerable to the hemodynamic consequences of untreated adrenal insufficiency, as inadequate cortisol impairs vascular responsiveness to catecholamines. 1, 2
  • Prolonged critical illness (post-CABG, pancreatitis, septic shock) may have suppressed the hypothalamic-pituitary-adrenal axis through sustained high cortisol levels, further impairing adrenal responsiveness. 3, 9

References

Research

Adrenal insufficiency in sepsis.

Current pharmaceutical design, 2008

Research

Adrenal insufficiency during septic shock.

Critical care medicine, 2003

Research

Critical Illness-induced Corticosteroid Insufficiency: What It Is Not and What It Could Be.

The Journal of clinical endocrinology and metabolism, 2022

Guideline

First‑Line Inotropic and Vasopressor Therapy in Cardiogenic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vasopressor Management in Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Norepinephrine Dosing in Cardiogenic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management approach for a patient with adrenal hemorrhage, potentially with underlying bleeding disorders or anticoagulation, and presenting with hypotension and impaired coagulation profile?
What are the treatment options for cortisol imbalance?
What is the recommended treatment for critical illness-related corticosteroid (CS) insufficiency?
What is the appropriate dosing of injectable hydrocortisone for children in adrenal crisis, severe allergic reaction (anaphylaxis), status asthmaticus, and refractory shock?
What is the most important medication to give to a 30-year-old female patient with a history of ulcerative colitis (UC), adrenal disease, and current symptoms of septic shock, hyponatremia, hypoglycemia, hyperkalemia, acute kidney injury, non-anion gap metabolic acidosis, and eosinophilia?
What first‑line alternative to oxybutynin can be used for over‑active bladder or urge incontinence, especially in older adults or patients with dementia, glaucoma, urinary retention, or uncontrolled hypertension?
What is the recommended intravenous labetalol dosing regimen for an adult with hypertensive encephalopathy?
What is the diagnosis and recommended work‑up and management for a patient with liver biopsy showing established cirrhosis characterized by a nodular surface and peri‑portal fibrosis, without significant steatosis or iron deposition?
How should I manage a patient with right‑sided ear discharge (otorrhea) when the tympanic membrane cannot be visualized?
How should I treat a patient with acute bacterial pansinusitis?
Can sertraline and trazodone be co‑administered in an adult patient without hepatic or renal impairment, prolonged QT interval, other serotonergic agents, uncontrolled hypertension, or severe orthostatic hypotension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.